Sugi Predict

Sugi Predict / Compounds / SCHEMBL1495213

SCHEMBL1495213

SCHEMBL1495213

Cc1ccc(O)c(Cn2c(NC3CCN(CCOC(N)=O)CC3)nc3c(C)cccc32)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 7/20 0.39
▸ NR4A2 P43354 1/20 0.39
▸ NPY1R P25929 4/20 0.37
▸ SSTR5 P35346 5/20 0.37
▸ CHRM2 P08172 2/20 0.37
▸ CHRM4 P08173 2/20 0.37
▸ CHRM5 P08912 2/20 0.37
▸ CHRM1 P11229 2/20 0.37
▸ CHRM3 P20309 2/20 0.37
▸ HRH1 P35367 2/20 0.37
▸ HRH4 Q9H3N8 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MLNR O43193 1/20 0.37
▸ CACNA1F O60840 1/20 0.37
▸ EED O75530 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ABCB11 O95342 1/20 0.37
▸ EGFR P00533 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1495236 0.89 NPY1R (0.42) KCNH2NR4A2NPY1RSSTR5CHRM2
SCHEMBL1495206 0.88 SSTR5 (0.41) KCNH2NR4A2NPY1RSSTR5CHRM2
Jnj 2408068 SCHEMBL29427933 0.87 KCNH2 (0.42) KCNH2NR4A2SSTR5CHRM2CHRM4
Jnj 2408068 SCHEMBL3890162 0.87 KCNH2 (0.42) KCNH2NR4A2SSTR5CHRM2CHRM4
Jnj 2408068 SCHEMBL29623997 0.87 KCNH2 (0.42) KCNH2NR4A2SSTR5CHRM2CHRM4
Jnj 2408068 SCHEMBL29365461 0.87 KCNH2 (0.42) KCNH2NR4A2SSTR5CHRM2CHRM4
SCHEMBL1495344 0.87 NPY1R (0.44) KCNH2NR4A2NPY1RSSTR5CHRM2
Jnj 2408068 SCHEMBL4980538 0.87 KCNH2 (0.42) KCNH2NR4A2SSTR5CHRM2CHRM4
SCHEMBL1495258 0.86 SSTR5 (0.40) KCNH2NR4A2NPY1RSSTR5CHRM2
SCHEMBL4776300 0.86 KCNH2 (0.43) KCNH2NR4A2NPY1RSSTR5CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723136-B1 PIPERIDINE-AMINO-BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARM LTD (IE) 2011-03-09 — — EP disclosed
US-20080146613-A1 PIPERIDINE-AMINO-BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-06-19 — — US disclosed
US-7355051-B2 Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2008-04-08 — — US disclosed
US-20070093659-A1 Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093659-A1 Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication NQO2, NOX1, NOX3 KCNH2 347/4885NR4A2 388/4885NPY1R 3876/4885
US-20080146613-A1 PIPERIDINE-AMINO-BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION NQO2, NOX3, NOX1 KCNH2 487/4885NR4A2 311/4885NPY1R 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback